HB3834

Ibogaine clinical trials; Oklahoma Breakthrough Therapy Act; terms; requirements for drug developers; contractual terms; intellectual property rights; reports; intellectual property account; Office of the State Treasurer; adverse licensing action; effective date.

Authored by Representative May

Official Bill Page

Org Votes

✅ Support (0):

❌ Oppose (0):

🟡 Neutral (0):

Text Versions

• Introduced